Literature DB >> 18283486

Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Jan-Bart M Koorstra1, Georg Feldmann, Nils Habbe, Anirban Maitra.   

Abstract

INTRODUCTION: Pancreatic ductal adenocarcinoma (i.e., pancreatic cancer) is an almost universally lethal disease. The identification of precursor lesions of pancreatic cancer provides an opportunity for early detection and potential therapeutic intervention before the development of invasive cancer. DISCUSSION: It is now established that pancreatic cancers do not arise de novo but rather exhibit a sequential histological and genetic progression of precursor lesions culminating in frank, invasive neoplasia. Pancreatic intraepithelial neoplasia (PanIN) is the most common non-invasive precursor lesion of pancreatic cancer. The development of a consensus nomenclature scheme for PanINs has facilitated research into pancreatic cancer precursors and enabled standardization of results across institutions.
CONCLUSION: PanINs harbor many of the molecular alterations observed in invasive pancreatic cancer, confirming their status as true non-invasive precursor lesions. Recently developed genetically engineered mouse models of pancreatic cancer also demonstrate the stepwise PanIN progression model, underscoring the commonalities in pancreatic neoplasia between mouse and man.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283486      PMCID: PMC2666329          DOI: 10.1007/s00423-008-0282-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  101 in total

1.  Fanconi anemia gene mutations in young-onset pancreatic cancer.

Authors:  Michiel S van der Heijden; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

Review 2.  Ras redux: rethinking how and where Ras acts.

Authors:  Sunil R Hingorani; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

3.  Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.

Authors:  N Tjarda van Heek; Alan K Meeker; Scott E Kern; Charles J Yeo; Keith D Lillemoe; John L Cameron; G Johan A Offerhaus; Jessica L Hicks; Robb E Wilentz; Michael G Goggins; Angelo M De Marzo; Ralph H Hruban; Anirban Maitra
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

Authors:  N Volkan Adsay; Kambiz Merati; Aleodor Andea; Fazlul Sarkar; Ralph H Hruban; Robb E Wilentz; Micheal Goggins; Christine Iocobuzio-Donahue; Daniel S Longnecker; David S Klimstra
Journal:  Mod Pathol       Date:  2002-10       Impact factor: 7.842

Review 5.  Pancreatic cancer biology and genetics.

Authors:  Nabeel Bardeesy; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

6.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.

Authors:  Yoshiharu Miyamoto; Anirban Maitra; Bidyut Ghosh; Ulrich Zechner; Pedram Argani; Christine A Iacobuzio-Donahue; Virote Sriuranpong; Tatsuya Iso; Ingrid M Meszoely; Michael S Wolfe; Ralph H Hruban; Douglas W Ball; Roland M Schmid; Steven D Leach
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  Telomere dysfunction provokes regional amplification and deletion in cancer genomes.

Authors:  Rónán C O'Hagan; Sandy Chang; Richard S Maser; Ramya Mohan; Steven E Artandi; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

8.  Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.

Authors:  Grace E Kim; Han-Ik Bae; Hee-Ug Park; Shih-Fan Kuan; Suzanne C Crawley; Jenny J L Ho; Young S Kim
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  BRCA2 germline mutations in familial pancreatic carcinoma.

Authors:  Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

Review 10.  Intraductal papillary mucinous tumors of the pancreas.

Authors:  Friedrich H Schmitz-Winnenthal; Kaspar Z'graggen; Christine Volk; Bruno M Schmied; Markus W Büchler
Journal:  Curr Gastroenterol Rep       Date:  2003-04
View more
  14 in total

1.  A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin.

Authors:  Maeve Lowery; David Klimstra; Cyrus Hedvat; William Jarnagin; Dennis Chi; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-03

Review 2.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

Review 3.  Advances in biomarker research for pancreatic cancer.

Authors:  Kruttika Bhat; Fengfei Wang; Qingyong Ma; Qinyu Li; Sanku Mallik; Tze-Chen Hsieh; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.

Authors:  Xianzhou Song; Hui Chen; Chengwei Zhang; Yang Yu; Zhongyuan Chen; Han Liang; George Van Buren; Amy L McElhany; William E Fisher; David M Lonard; Bert W O'Malley; Jin Wang
Journal:  Cancer Lett       Date:  2018-11-10       Impact factor: 8.679

5.  Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Atsushi Enomoto; Masato Nagino
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

Review 6.  Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Authors:  Fan Lei; Xinyuan Xi; Surinder K Batra; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-02-22       Impact factor: 4.030

7.  Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico.

Authors:  Emine Güven
Journal:  Iran J Biotechnol       Date:  2022-01-01       Impact factor: 1.266

8.  Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia.

Authors:  Jan-Bart M Koorstra; Seung-Mo Hong; Chanjuan Shi; Alan K Meeker; Ji Kon Ryu; George Johan A Offerhaus; Michael G Goggins; Ralph H Hruban; Anirban Maitra
Journal:  Mod Pathol       Date:  2009-08-07       Impact factor: 7.842

9.  The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.

Authors:  Niels C B Nyborg; Anne-Marie Mølck; Lars W Madsen; Lotte Bjerre Knudsen
Journal:  Diabetes       Date:  2012-02-14       Impact factor: 9.461

Review 10.  Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.

Authors:  M Distler; D Aust; J Weitz; C Pilarsky; Robert Grützmann
Journal:  Biomed Res Int       Date:  2014-03-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.